Candel Therapeutics, INC. (CADL) — DEF 14A Filings

All DEF 14A filings from Candel Therapeutics, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.

DEF 14A Filings (2)

Candel Therapeutics Files 2025 Proxy Statement — Apr 29, 2025 Risk: low
Candel Therapeutics, Inc. filed its definitive proxy statement (DEF 14A) on April 29, 2025, for its annual meeting on June 17, 2025. The filing outlines the com
Candel Therapeutics Files Proxy Statement for Annual Meeting — May 30, 2024 Risk: medium
Candel Therapeutics, Inc. filed a Definitive Proxy Statement (DEF 14A) on May 30, 2024, for its annual meeting of stockholders scheduled for June 26, 2024. The

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX